Real-World Effectiveness, Tolerability and Safety of Cyclosporine A 0.1% Cationic Emulsion in Severe Keratitis and Dry Eye Treatment

[11] Downie LE(2020)Inflammatory basis for dry eye disease flares Exp Eye Res 201 108294-167

[12] Korb D(2019)Depressive symptoms, resilience, and personality traits in dry eye disease Graefes Arch Clin Exp Ophthalmol 257 591-2223

[13] Rolando M(2016)Economic and humanistic burden of dry eye disease in Europe, North America, and Asia: a systematic literature review Ocul Surf 14 144-5727

[14] Refojo MF(2017)Health-related quality of life and depression among participants in the Sjögren's International Collaborative Clinical Alliance registry RMD Open 3 e000495-57

[15] Kenyon KR(2018)Dry eye N Engl J Med 378 2212-586

[16] Baudouin C(2012)Assessment of vision-related quality of life in dry eye patients Invest Ophthalmol Vis Sci 53 5722-412

[17] Messmer EM(2013)Dry eye disease: impact on quality of life and vision Curr Ophthalmol Rep 1 51-131

[18] Aragona P(2017)Keratitis in dry eye disease and topical ciclosporin A Ocul Immunol Inflamm 25 577-296

[19] Baudouin C(2009)Etiology, prevalence, and treatment of dry eye disease Clin Ophthalmol 3 405-685

[20] Irkeç M(2019)Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies Br J Ophthalmol 103 125-530

[11] Downie LE(2020)Inflammatory basis for dry eye disease flares Exp Eye Res 201 108294-167

[12] Korb D(2019)Depressive symptoms, resilience, and personality traits in dry eye disease Graefes Arch Clin Exp Ophthalmol 257 591-2223

[13] Rolando M(2016)Economic and humanistic burden of dry eye disease in Europe, North America, and Asia: a systematic literature review Ocul Surf 14 144-5727

[14] Refojo MF(2017)Health-related quality of life and depression among participants in the Sjögren's International Collaborative Clinical Alliance registry RMD Open 3 e000495-57

[15] Kenyon KR(2018)Dry eye N Engl J Med 378 2212-586

[16] Baudouin C(2012)Assessment of vision-related quality of life in dry eye patients Invest Ophthalmol Vis Sci 53 5722-412

[17] Messmer EM(2013)Dry eye disease: impact on quality of life and vision Curr Ophthalmol Rep 1 51-131

[18] Aragona P(2017)Keratitis in dry eye disease and topical ciclosporin A Ocul Immunol Inflamm 25 577-296

[19] Baudouin C(2009)Etiology, prevalence, and treatment of dry eye disease Clin Ophthalmol 3 405-685

[20] Irkeç M(2019)Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies Br J Ophthalmol 103 125-530